Industry News

Interview eureKARE SAB – Pamela Silver

Pamela Silver, one of the founding members of the Department of System Biology at HMX – Harvard Medical School and member of our Scientific Advisory Board, highlights the potential and direction of synthetic biology over the coming years.

Human microbiome market size worth $1.7 bn by 2027

Increasing Awareness of Human Microbiome Therapy and the Rising Incidence of Chronic Diseases is Driving Human Microbiome Industry Demand.

Five Disruptive Innovations Affecting Various Industries In 2021

Jack Uldrich is a leading global futurist, best-selling author, and keynote speaker. He is also the founder/CEO of The School of Unlearning.

Disruption of the gut microbiome and Covid-19

The human gastrointestinal (GI) tract contains over 1,000 symbiotic and pathogenic microorganisms, which are known to play a key role in health via host metabolism, physiology, nutrition, and immune function.

How gut microbes could drive brain disorders

Scientists are starting to work out how the gut microbiome can affect brain health. That might lead to better and easier treatments for brain diseases.

The Unexplored Power of Microbes​

Microbes are the most prolific and diverse group of organisms on the planet. These tiny creatures are also incredibly useful. Researchers and biotech entrepreneurs employ microbes to produce medicines, alternative proteins  and so much more.

Synthetic biology market expected to reach $35bn by 2026

The global demand for synthetic biology market in terms of revenue was estimated to be USD 7.54 Billion in 2019

Learn about

Luxembourg | France | Belgium

Subscribe to our news to keep in touch

Luxembourg | France | Belgium